The present meta-analysis found that compared to a low dose, the standard dose of tPA was effective in enhancing favorable outcomes in patients with acute ischemic stroke without significantly increasing the risk of symptomatic ICH, asymptomatic ICH, and parenchymal hematomas. Here, PLAT is linked to hematoma.